Sick building syndrome, long dismissed by mainstream medicine as a psychosomatic phenomenon, is gaining formal recognition as a legitimate medical diagnosis, with a growing body of research identifying indoor mold growth and volatile organic compound accumulation as primary drivers.
A consensus statement published in the Annals of Internal Medicine in February 2026 and endorsed by the American College of Occupational and Environmental Medicine defines sick building syndrome as a clinical entity characterized by headache, fatigue, mucous membrane irritation, and cognitive impairment that are temporally linked to time spent in a specific building and resolve when the individual leaves that environment.
The statement identifies water-damaged buildings with active mold growth as the most common underlying cause, followed by inadequate ventilation and chemical off-gassing from building materials. It recommends that physicians document building exposure history and refer patients to certified industrial hygienists for environmental assessment.
The recognition has significant implications for workers compensation, disability claims, and housing litigation. Attorneys representing clients in mold-related cases have noted that the consensus statement provides a new evidentiary foundation for claims that were previously difficult to substantiate.
For restoration professionals, the consensus statement reinforces the medical necessity of thorough remediation and post-remediation verification testing. It also underscores the importance of documenting pre- and post-remediation air quality data.
